Analysts’ Viewpoint on Global Market Scenario
Even though elective procedures have been postponed indefinitely during the ongoing COVID-19 outbreak, healthcare facilities are ensuring continuity in services for key sectors such as blood screening and detection of infectious diseases, among others. However, in many cases, it has been found that late diagnosis of any disease results in rise in the cost of treatment. Hence, companies in the molecular diagnostics market should increase R&D to enable early detection of diseases and invest in marketing of tests to increase awareness about its advantages for early disease diagnosis. Alternatively, the strong growth of molecular diagnostics in Germany can be attributed to the government’s focus on healthcare investments, enhancing the biotechnology sector, and increasing the number of biotechnology companies in the country.
North America dominated the global market for molecular diagnostics in 2020, followed by Europe. The region's dominance can be attributed to the increase in diagnostic facilities and the emergence of new players in the region. North America is the leading market for molecular diagnostics due to the rise in investments by governments in support of molecular diagnostic tests. A surge in the incidence of cancer and unhealthy lifestyle leading to severe infectious diseases are fueling the growth of the molecular diagnostics market in the region. Other factors such as the large geriatric population and the rise in demand for personalized medicines are expected to augment the market in North America.
Emerging markets in Asia Pacific hold immense growth potential due to initiatives taken by governments to promote healthcare and robust economic growth. Moreover, improving purchasing power, consumer awareness about health issues, and better disease management are expected to boost the growth of the global market for molecular diagnostics in the Asia Pacific.
In order to keep the economies running amid the ongoing COVID-19 outbreak, companies in the global molecular diagnostics market are increasing R&D in PCR (Polymerase Chain Reaction) & real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing, etc.
The PCR & real-time PCR segment accounted for a leading revenue share of the global market in 2020. The segment is likely to witness strong growth during the forecast period, as the PCR technique is a cost-effective way of copying or amplification of small segments of DNA or RNA. The unprecedented demand for RT-PCR tests during the ongoing pandemic is propelling the market growth.
Less awareness and ambiguity about diagnostic techniques for detecting various infectious & chronic diseases is a major factor limiting the penetration of tests, such as HIV tests, healthcare-acquired infection tests, and rapid molecular tests in the mycobacterium tuberculosis into the molecular diagnostics market. Therefore, small and medium community medical practitioners in emerging economies such as China and India need to be educated about the availability of these tests, and how these can be used for the prevention and diagnosis of chronic diseases. Stakeholders in this market should increase marketing and awareness about molecular diagnostic tests to increase their acceptance among people in developing economies.
Companies in the Europe molecular diagnostics market are focusing on hospitals, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnology companies to expand their business activities. Pharmaceutical and biotechnology companies are anticipated to be the fastest growing segment, owing to their increasing investments in research that contribute to the growth in the adoption of molecular diagnostic devices. This segment is closely trailed by academic and research institutes. The growth in this segment can be attributed to the increasing public and private funding for research. European funding organizations are supporting innovative companies in the development of new products and are conducting annual PCR conferences to identify potential innovators of PCR technology.
The demand for molecular diagnostic systems has been increasing, owing to the increasing automation in the research process. These systems aid in automating the process of DNA extraction, amplification, and recording the analysis of data. In addition, these systems offer a range of advantages such as increased efficiency, the correctness of the data, and a decrease in the time required for results, which contribute to garnering market growth.
Companies are increasing efforts toward high-throughput molecular testing of infectious diseases. They are entering into agreements to provide molecular diagnostic tests, which are designed for the detection of various pathogens with a single patient sample.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 14.99 Bn |
|
Market Forecast Value in 2028 |
US$ 37.19 Bn |
|
Growth Rate (CAGR) |
11.1% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes cross-segment analysis at the global as well as regional levels. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Molecular Diagnostics Market – Segmentation
| Technology |
|
| Application |
|
| End-user |
|
| Region |
|
The global market for molecular diagnostics was worth US$ 14.99 Mn and is projected to reach a value of US$ 37.19 Bn by the end of 2028
The global market is anticipated to grow at a CAGR of 11.1% during the forecast period
North America accounted for a major share of the global market for molecular diagnostics
The market is driven by an increase in the geriatric population, a rise in demand for personalized health care, and a surge in awareness about molecular diagnostics are the key factors projected to drive the global market during the forecast period
Key players in the global market include Abbot Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche Ltd., QIAGEN N.V., Siemens AG, and Thermo Fisher Scientific, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Molecular Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. End-user Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Molecular Diagnostics Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Future Market Outlook
5.2. Key Industry Events
5.3. Porter’s Five Force Analysis
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Molecular Diagnostics Market Analysis and Forecast, by End-user
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by End-user, 2017–2028
6.3.1. PCR & Real-time PCR
6.3.2. Hybridization
6.3.3. Microarray
6.3.4. Transcription-mediated Amplification
6.3.5. Next-Generation Sequencing
6.3.6. Others
6.4. Market Attractiveness Analysis, by End-user
7. Global Molecular Diagnostics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2028
7.3.1. Infectious Diseases
7.3.1.1. Virology
7.3.1.2. Bacteriology
7.3.2. Oncology
7.3.3. Blood Screening
7.3.4. Microbiology
7.3.5. Genetic Testing
7.3.6. Women’s Health
7.4. Market Attractiveness Analysis, by Application
8. Global Molecular Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2028
8.3.1. Hospitals
8.3.2. Diagnostics Laboratories
8.3.3. Blood Banks
8.3.4. Academics & Research
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Molecular Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Molecular Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by End-user, 2017–2028
10.2.1. PCR & Real-time PCR
10.2.2. Hybridization
10.2.3. Microarray
10.2.4. Transcription-mediated Amplification
10.2.5. Next-Generation Sequencing
10.2.6. Others
10.3. Market Value Forecast, by Application, 2017–2028
10.3.1. Infectious Diseases
10.3.1.1. Virology
10.3.1.2. Bacteriology
10.3.2. Oncology
10.3.3. Blood Screening
10.3.4. Microbiology
10.3.5. Genetic Testing
10.3.6. Women’s Health
10.4. Market Value Forecast, by End-user, 2017–2028
10.4.1. Hospitals
10.4.2. Diagnostics Laboratories
10.4.3. Blood Banks
10.4.4. Academics & Research
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By End-user
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Molecular Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by End-user, 2017–2028
11.2.1. PCR & Real-time PCR
11.2.2. Hybridization
11.2.3. Microarray
11.2.4. Transcription-mediated Amplification
11.2.5. Next-Generation Sequencing
11.2.6. Others
11.3. Market Value Forecast, by Application, 2017–2028
11.3.1. Infectious Diseases
11.3.1.1. Virology
11.3.1.2. Bacteriology
11.3.2. Oncology
11.3.3. Blood Screening
11.3.4. Microbiology
11.3.5. Genetic Testing
11.3.6. Women’s Health
11.4. Market Value Forecast, by End-user, 2017–2028
11.4.1. Hospitals
11.4.2. Diagnostics Laboratories
11.4.3. Blood Banks
11.4.4. Academics & Research
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By End-user
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by End-user, 2017–2028
12.2.1. PCR & Real-time PCR
12.2.2. Hybridization
12.2.3. Microarray
12.2.4. Transcription-mediated Amplification
12.2.5. Next-Generation Sequencing
12.2.6. Others
12.3. Market Value Forecast, by Application, 2017–2028
12.3.1. Infectious Diseases
12.3.1.1. Virology
12.3.1.2. Bacteriology
12.3.2. Oncology
12.3.3. Blood Screening
12.3.4. Microbiology
12.3.5. Genetic Testing
12.3.6. Women’s Health
12.4. Market Value Forecast, by End-user, 2017–2028
12.4.1. Hospitals
12.4.2. Diagnostics Laboratories
12.4.3. Blood Banks
12.4.4. Academics & Research
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By End-user
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Molecular Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by End-user, 2017–2028
13.2.1. PCR & Real-time PCR
13.2.2. Hybridization
13.2.3. Microarray
13.2.4. Transcription-mediated Amplification
13.2.5. Next-Generation Sequencing
13.2.6. Others
13.3. Market Value Forecast, by Application, 2017–2028
13.3.1. Infectious Diseases
13.3.1.1. Virology
13.3.1.2. Bacteriology
13.3.2. Oncology
13.3.3. Blood Screening
13.3.4. Microbiology
13.3.5. Genetic Testing
13.3.6. Women’s Health
13.4. Market Value Forecast, by End-user, 2017–2028
13.4.1. Hospitals
13.4.2. Diagnostics Laboratories
13.4.3. Blood Banks
13.4.4. Academics & Research
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By End-user
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Molecular Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by End-user, 2017–2028
14.2.1. PCR & Real-time PCR
14.2.2. Hybridization
14.2.3. Microarray
14.2.4. Transcription-mediated Amplification
14.2.5. Next-Generation Sequencing
14.2.6. Others
14.3. Market Value Forecast, by Application, 2017–2028
14.3.1. Infectious Diseases
14.3.1.1. Virology
14.3.1.2. Bacteriology
14.3.2. Oncology
14.3.3. Blood Screening
14.3.4. Microbiology
14.3.5. Genetic Testing
14.3.6. Women’s Health
14.4. Market Value Forecast, by End-user, 2017–2028
14.4.1. Hospitals
14.4.2. Diagnostics Laboratories
14.4.3. Blood Banks
14.4.4. Academics & Research
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By End-user
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Becton, Dickinson and Company
15.3.2.1. Company Overview
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Bio-Rad Laboratories, Inc.
15.3.3.1. Company Overview
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. BioMérieux SA
15.3.4.1. Company Overview
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Danaher Corporation
15.3.5.1. Company Overview
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. F. Hoffmann-La Roche Ltd.
15.3.6.1. Company Overview
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. QIAGEN N.V.
15.3.7.1. Company Overview
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Siemens AG
15.3.8.1. Company Overview
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Thermo Fisher Scientific Inc.
15.3.9.1. Company Overview
15.3.9.2. Business Overview
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
List of Table
Table 01: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 02: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028
Table 03: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028
Table 04: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 05: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2028
Table 06: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028
Table 07: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028
Table 08: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028
Table 09: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 10: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2028
Table 11: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 12: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028
Table 13: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028
Table 14: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 15: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 16: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028
Table 17: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028
Table 18: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028
Table 19: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 20: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 21: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028
Table 22: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028
Table 23: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028
Table 24: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 25: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 26: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 27: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028
Table 28: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028
Table 29: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 30: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
List of Figure
Figure 1: Global Molecular Diagnostic Market Size (US$ Mn) Forecast, 2017–2028
Figure 2: Global Molecular Diagnostics Market Value Share, by Technology, 2020
Figure 3: Global Molecular Diagnostics Market Value Share, by Application, 2020
Figure 4: Global Molecular Diagnostics Market Value Share, by Region, 2020
Figure 5: Global Molecular Diagnostics Market Value Share, by End-user, 2020
Figure 6: Global Molecular Diagnostic Market Value Share Analysis, by Technology, 2017 and 2028
Figure 7: Global Molecular Diagnostic Market Attractiveness Analysis, by Technology, 2021–2028
Figure 8: Global PCR & Real-time PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 9: Global Hybridization Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 10: Global Microarray Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 11: Global Transcription-mediated Amplification Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 12: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 13: Global Others (Mass Spectrometry etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2028
Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2021–2022
Figure 16: Global Infectious Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 17: Global Oncology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 18: Global Blood Screening Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 19: Global Microbiology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 20: Global Genetic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 21: Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 22: Global Molecular Diagnostic Market Value Share Analysis, by End-user, 2017 and 2028
Figure 23: Global Molecular Diagnostic Market Attractiveness Analysis, by End-user, 2021–2022
Figure 24: Global Hospital Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 25: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 26: Global Blood Banks Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 27: Global Academics & Research Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028
Figure 29: Global Molecular Diagnostics Market Value Share Analysis, by Region, 2017 and 2028
Figure 30: Global Molecular Diagnostics Market Attractiveness Analysis, by Region, 2021–2022
Figure 31: North America Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 32: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022
Figure 33: North America Market Value Share Analysis, by Technology Type, 2017 and 2028
Figure 34: North America Market Value Share Analysis, by Application, 2017 and 2028
Figure 35: North America Market Value Share Analysis, by End-user, 2017 and 2028
Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2028
Figure 37: North America Market Attractiveness Analysis, by Technology, 2021–2022
Figure 38: North America Market Attractiveness Analysis, by Application, 2021–2022
Figure 39: North America Market Attractiveness Analysis, by End-user, 2021–2022
Figure 40: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 41: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022
Figure 42: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2017 and 2028
Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2028
Figure 44: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2017 and 2028
Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2017 and 2028
Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2021–2022
Figure 47: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application, 2021–2022
Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2021–2022
Figure 49: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 50: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022
Figure 51: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2028
Figure 52: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2028
Figure 53: Asia Pacific Market Value Share Analysis, by End-user, 2017 and 2028
Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2028
Figure 55: Asia Pacific Market Attractiveness Analysis, by Technology, 2021–2022
Figure 56: Asia Pacific Market Attractiveness Analysis, by Application, 2021–2022
Figure 57: Asia Pacific Market Attractiveness Analysis, by End-user, 2021–2022
Figure 58: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 59: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022
Figure 60: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2028
Figure 61: Latin America Market Value Share Analysis, by Application, 2017 and 2028
Figure 62: Latin America Market Value Share Analysis, by End-user, 2017 and 2028
Figure 63: Latin America Market Value Share Analysis, by Country, 2017 and 2028
Figure 64: Latin America Market Attractiveness Analysis, by Technology, 2021–2022
Figure 65: Latin America Market Attractiveness Analysis, by Application, 2021–2022
Figure 66: Latin America Market Attractiveness Analysis, by End-user, 2021–2022
Figure 67: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 68: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022
Figure 69: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2028
Figure 70: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2028
Figure 71: Middle East & Africa Market Value Share Analysis, by End-user, 2017 and 2028
Figure 72: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2028
Figure 73: Middle East & Africa Market Attractiveness Analysis, by Technology, 2021–2022
Figure 74: Middle East & Africa Market Attractiveness Analysis, by Application, 2021–2022
Figure 75: Middle East & Africa Market Attractiveness Analysis, by End-user, 2021–2022
Figure 76: Global Molecular Diagnostics Market Share Analysis, by Company
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Molecular Diagnostics Market
